Trials Sponsors Conditions Drugs Pricing

Conditions

Hepatitis C Virus Infection

Outcome Measures

Primary Outcomes (2)

Retrospective data collection
Prevalence of diagnosed but untreated HCV patients through positive serology with positive or unknown HCV RNA in UZ Brussel between 2012 - 2022.
before contacting the patient
Prospective interventional study
To recall DBU patients by phone, e-mail or letter, trying to optimize treated and cured patients after recall
from first contact of the patient till 12 weeks after end of treatment.

Secondary Outcomes (1)

Reason lost in follow-up
from first contact of the patient till 12 weeks after end of treatment.

Study Arms (1)

Diagnosed-but-untreated

Diagnosed but untreated (DBU) HCV patients through positive serology with positive or unknown HCV RNA in UZ Brussel between 2012 - 2022.

Other: Contact the patient

Interventions

Contact the patientOther

Phone call, email or letter to contact the patient to relink them.

Diagnosed-but-untreated

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Positive hepatitis C serology with positive or unknown HCV RNA.

You may qualify if:

Positive HCV serology between 2012-2022 with positive or uknown HCV RNA in UZ Brussels database

Sponsors & Collaborators

Universitair Ziekenhuis Brussel
Otherlead

Study Sites (1)

UZ Brussel

Brussels, 1090, Belgium

MeSH Terms

Conditions

Hepatitis C

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsHepatitis, Viral, HumanVirus DiseasesFlaviviridae InfectionsRNA Virus InfectionsHepatitisLiver DiseasesDigestive System Diseases

Enrollment

600 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: OTHER
Time Perspective: OTHER
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

July 18, 2023

First Posted

August 3, 2023

Study Start

July 6, 2023

Actual (reported)

Primary Completion

Relinking Diagnosed But Untreated HCV Patients Back Into Care.

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (1)

Study Arms (1)

Diagnosed-but-untreated

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (1)

Study Arms (1)

Diagnosed-but-untreated

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations